Cite
MLA Citation
M Gross-Goupil et al.. “Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial.” Annals of oncology, vol. 29, 2018, pp. 2371–2378. http://access.bl.uk/ark:/81055/vdc_100095487005.0x00003a